Abstract OT1-03-05: A phase III, randomized, open label, multicenter, controlled trial of niraparib versus physician's choice in previously- treated, HER2 negative, germline BRCA mutation-positive breast cancer patients. An EORTC-BIG intergroup study (BRAVO study)

Mapping Intimacies ◽

10.1158/1538-7445.sabcs15-ot1-03-05 ◽

2016 ◽

Cited By ~ 1

Author(s):

J Balmana ◽

K Tryfonidis ◽

W Audeh ◽

T Goulioti ◽

L Slaets ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Brca Mutation ◽

Phase Iii ◽

Breast Cancer Patients ◽

Open Label ◽

Germline Brca Mutation ◽

Previously Treated ◽

Positive Breast Cancer

Download Full-text

Efficacy and safety of taxane plus anthracycline with or without cyclophosphamide in Chinese node-positive breast cancer patients: an open-label, randomized controlled trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05207-x ◽

2019 ◽

Vol 175 (3) ◽

pp. 659-666

Author(s):

Yan Lin ◽

Changjun Wang ◽

Xin Huang ◽

Xingtong Zhou ◽

Yidong Zhou ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Controlled Trial ◽

Cancer Patients ◽

Controlled Trial ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Open Label ◽

Node Positive ◽

Randomized Controlled ◽

Positive Breast Cancer

Download Full-text

A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation

Case Medical Research ◽

10.31525/ct1-nct04296370 ◽

2020 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Brca Mutation ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Chemotherapy Treatment ◽

Germline Brca Mutation

Download Full-text

Hypofractionated (HF) Versus Conventional Fractionated (CF) Radiotherapy for Breast Cancer Patients Treated with Breast Conserving Surgery: A Randomized, Phase III, Open-Label, Non-Inferiority Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.1029 ◽

2020 ◽

Vol 108 (3) ◽

pp. e18

Author(s):

S.L. Wang ◽

Y.W. Song ◽

C. Hu ◽

W.H. Wang ◽

H. Fang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Conserving Surgery ◽

Phase Iii ◽

Breast Cancer Patients ◽

Open Label

Download Full-text

11 Lymph node ratio is an independent risk classifier in node positive breast cancer patients: results of the phase III BIG 02-98 trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70043-4 ◽

2010 ◽

Vol 8 (3) ◽

pp. 61 ◽

Cited By ~ 2

Author(s):

O. Metzger ◽

E. de Azambuja ◽

E. Quinaux ◽

P. Francis ◽

M. Buyse ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Cancer Patients ◽

Lymph Node Ratio ◽

Phase Iii ◽

Breast Cancer Patients ◽

Node Positive ◽

Node Ratio ◽

Positive Breast Cancer

Download Full-text

A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy097 ◽

2018 ◽

Vol 48 (9) ◽

pp. 855-859 ◽

Cited By ~ 2

Author(s):

Yutaka Yamamoto ◽

Hiroji Iwata ◽

Takayuki Ueno ◽

Naruto Taira ◽

Masahiro Kashiwaba ◽

...

Keyword(s):

Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Phase Iii ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase ◽

Previously Treated

Download Full-text

Prognostic and predictive value of TP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial

Breast Cancer Research ◽

10.1186/bcr3179 ◽

2012 ◽

Vol 14 (3) ◽

Cited By ~ 46

Author(s):

Lynnette Fernández-Cuesta ◽

Catherine Oakman ◽

Priscila Falagan-Lotsch ◽

Ke-seay Smoth ◽

Emmanuel Quinaux ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Cancer Patients ◽

Predictive Value ◽

Phase Iii ◽

Breast Cancer Patients ◽

Phase Iii Trial ◽

Node Positive ◽

Positive Breast Cancer

Download Full-text

Additional Safety Results of Hannah: A Phase III Randomised, Open-Label, International Study of the Subcutaneous Formulation of Trastuzumab (H) in HER2-Positive Early Breast Cancer Patients

Annals of Oncology ◽

10.1016/s0923-7534(20)32833-7 ◽

2012 ◽

Vol 23 ◽

pp. ix102-ix103

Author(s):

C. Jackisch ◽

M. Dank ◽

G. Frasci ◽

K.H. Park ◽

R.I. Lopez ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

International Study ◽

Phase Iii ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Open Label ◽

Additional Safety

Download Full-text

Multicentric, open-label, single-arm phase II study with oral lapatinib in combination with oral capecitabine plus intrathecally administered liposomal cytarabine for the treatment of meningeal metastases (NM) in HER2-positive breast cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps123 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS123-TPS123

Author(s):

J. Bischoff

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Liposomal Cytarabine ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Open Label ◽

Oral Capecitabine ◽

Positive Breast Cancer

Download Full-text

Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial

Clinical Oncology ◽

10.1016/j.clon.2020.07.005 ◽

2021 ◽

Vol 33 (1) ◽

pp. 30-39

Author(s):

K. Joseph ◽

L.J. Vos ◽

Z. Gabos ◽

N. Pervez ◽

S. Chafe ◽

...

Keyword(s):

Breast Cancer ◽

Randomised Controlled Trial ◽

Cancer Patients ◽

Controlled Trial ◽

Intensity Modulated Radiotherapy ◽

Skin Toxicity ◽

Phase Iii ◽

Breast Cancer Patients ◽

Intensity Modulated ◽

Randomised Controlled

Download Full-text

Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.527 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 527-527 ◽

Cited By ~ 4

Author(s):

T. Saarto ◽

L. Vehmanen ◽

C. Blomqvist ◽

I. Elomaa

Keyword(s):

Breast Cancer ◽

Randomized Controlled Trial ◽

Cancer Patients ◽

Controlled Trial ◽

Breast Cancer Patients ◽

Node Positive ◽

Randomized Controlled ◽

Positive Breast Cancer

Download Full-text